Preparation H Multi-Symptom Interactions
There are 95 drugs known to interact with Preparation H Multi-Symptom (glycerin/petrolatum/phenylephrine/pramoxine topical), along with 3 disease interactions. Of the total drug interactions, 6 are major, and 89 are moderate.
- View all 95 medications that may interact with Preparation H Multi-Symptom
- View Preparation H Multi-Symptom disease interactions (3)
Most frequently checked interactions
View interaction reports for Preparation H Multi-Symptom (glycerin / petrolatum / phenylephrine / pramoxine topical) and the medicines listed below.
- acetaminophen
- amoxicillin
- azelastine nasal
- Claritin (loratadine)
- Colace (docusate)
- doxycycline
- famotidine
- Flonase (fluticasone nasal)
- fluconazole
- fluticasone nasal
- gabapentin
- hydroxyzine
- ibuprofen
- lisinopril
- Lyrica (pregabalin)
- magnesium oxide
- metformin
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Mucinex DM (dextromethorphan / guaifenesin)
- naltrexone
- nitrofurantoin
- Norco (acetaminophen / hydrocodone)
- oxycodone
- pantoprazole
- prednisone
- propranolol
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Preparation H Multi-Symptom disease interactions
There are 3 disease interactions with Preparation H Multi-Symptom (glycerin / petrolatum / phenylephrine / pramoxine topical) which include:
Report options
QR code containing a link to this page
More about Preparation H Multi-Symptom (glycerin / petrolatum / phenylephrine / pramoxine topical)
- Preparation H Multi-Symptom consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Drug class: anorectal preparations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.